Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare. Histologically, breast cancer can be classified into ductal carcinoma, lobular carcinoma, nipple cancer and other undifferentiated carcinoma. Invasive ductal carcinoma is the most common subtype accounting for 70 to 80 percent of all the breast cases. In women, breast cancer is the second most common form of cancer. GLOBOCAN reported that in the year 2012, breast cancer accounted for 11.9 percent of the total cancer cases and lead to 5,22,000 deaths worldwide.
Read the Report at?http://www.sandlerresearch.org/global-breast-cancer-market-2014-2018.html
The report covers the present scenario and the growth prospects of the Global Breast Cancer market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sale of drugs used for the management of breast cancers including but not limited to:
HER2-negative breast cancer
HER2-positive breast cancer
Hormone receptor positive breast cancer
Hormone receptor negative breast cancer
Advanced breast cancer
Early breast cancer
Operable node positive breast cancer
Metastatic breast cancer
Triple Negative Breast Cancer
Breast cancer is characterized by the uncontrolled growth of cancerous cells in the breast tissue. It occurs in both males and females; however, male breast cancer is rare.
Source: Rebecca Wilson, Sr. Research Analyst at SandlerResearch.org
I have Male Breast Cancer from 2011 – due to exposure from 9/11. I have no family history of breast cancer. I have so far been clear of continuing breast cancer. Doctors treated me in 2011 like women and created massive blood clots in my left lung and leg – I am lucky to be alive. DO NOT take Tomoxifin.